Skip to main content
. 2022 Jul 25;12(8):1211. doi: 10.3390/jpm12081211

Table 2.

Association between benign ovarian tumor and ovarian cancer patients. The results of independent sample t-test with blood samples, general biochemistry tests and tumor markers. N.B. BOT: Benign Ovarian Tumor; OC: Ovarian Cancer; SD: Standard Deviation.

Abbreviation Biomarkers Type Unit Mean ± SD 95% CI p
BOT OC
MPV Mean platelet volume full blood fL 9.98±1.78 10.09±1.69 (−0.48, 0.25) 0.55
BASO# Basophil cell count full blood 109/L 0.28±0.02 0.03±0.02 (−0.006, 0.002) 0.28
PHOS Phosphorus serum mmol/L 1.12±0.18 1.12±0.19 (−0.05, 0.03) 0.67
GLU Glucose serum mmol/L 5.56±1.18 5.12±0.85 (0.18, 0.69) <0.01
CA72-4 Carbohydrate antigen 72-4 serum U/mL 12.77±19.32 7.67±4.15 (2.18, 8.01) <0.01
K Kalium serum mmol/L 4.38±0.41 4.39±0.39 (−0.4, −1.17) 0.92
AST Aspartate aminotransferase serum u/L 20.94±9.36 17.34±6.88 (1.87, 5.32) <0.01
BASO% Basophil cell ratio full blood % 0.44±0.33 0.52±0.36 (−0.15, −0.001) 0.05
Mg Magnesium serum mmol/L 0.98±0.13 0.98±0.12 (−0.03, 0.02) 0.78
CL Chlorine serum mmol/L 100.9±3.52 100.73±2.36 (−0.05, 1.07) 0.6
CEA Carcinoembryonic antigen serum ng/mL 5.23±15.02 1.47±0.88 (1.55, 5.98) <0.01
EO# Eosinophil count full blood 109/L 0.06±0.06 0.07±0.08 (−0.03, 0.003) 0.13
CA19-9 Carbohydrate antigen 19-9 serum U/mL 66.66±166.39 25.91±40.36 (15.48, 66.01) <0.01
ALB Albumin serum g/L 38.94±6.27 43.13±3.92 (−5.29, −3.1) <0.01
IBIL Indirect bilirubin serum umol/L 5.36±2.51 6.54±3.15 (−1.77, −0.57) <0.01
GGT Gama glutamyl transferase serum u/L 22.79±17.22 19.88±18.48 (−0.85, 6.68) 0.13
MCH Mean corpuscular hemoglobin full blood Pg 28.34±2.71 29.2±2.36 (−1.39, −0.32) <0.01
GLO Globulin serum g/L 31.07±5.04 29.32±3.69 (0.83, 2.68) <0.01
ALT Alanine aminotransferase serum u/L 17.96±11.79 18.06±10.39 (−2.44, 2.23) 0.93
DBIL Direct bilirubin serum umol/L 2.9±1.34 3.35±1.45 (−0.74, −0.15) <0.01
RDW Red blood cell distribution width full blood % 13.68±2.0 13.43±1.59 (−0.13, 0.62) 0.2
PDW Platelet distribution width full blood % 13.91±3.19 14.74±2.74 (−1.46, −0.21) <0.01
CREA Creatinine serum umol/L 63.35±12.59 65.11±10.78 (−4.23, 0.7) 0.16
AFP Alpha-fetoprotein serum ng/mL 20.41±135.44 2.72±2.18 (−2.28, 37.66) 0.08
HGB Hemoglobin full blood g/L 122.21±16.71 128.34±13.7 (−9.35, −2.93) <0.01
Na Natrium serum mmol/L 140.91±3.26 140.1±2.35 (0.22, 1.42) <0.01
HE4 Human epididymis protein 4 serum pmol/L 324.24±488.62 49.17±39.07 (202.8, 347.34) <0.01
LYM# Lymphocyte count full blood 109/L 1.41±0.54 1.7±0.55 (−0.4, −0.17) <0.01
CA125 Carbohydrate antigen 125 serum U/mL 652.15±1021.91 51.45±79.79 (449.57, 751.81) <0.01
BUN Blood urea nitrogen serum mmol/L 4.0±1.42 4.02±1.15 (−0.28, 0.26) 0.94
LYM% Lymphocyte ratio full blood % 22.74±10.05 29.27±9.7 (−8.61, −4.46) <0.01
Ca Calcium serum mmol/L 2.32±0.42 2.46±0.28 (−0.21, −0.06) <0.01
AG Anion gap serum mmol/L 19.4±4.6 19.24±4.09 (−0.75, 1.08) 0.73
MONO# Mononuclear cell count full blood 109/L 0.39±0.16 0.33±0.13 (−0.03, 0.78) <0.01
PLT Platelet count full blood 109/L 281.65±117.44 230.25±57.33 (32.06, 70,74) <0.01
NEU Neutrophil ratio full blood % 70.21±10.92 63.09±7.5 (5.16, 9.09) <0.01
EO% Eosinophil ratio full blood 109/L 1.0±0.94 1.24±1.29 (−0.48, −0.004) 0.05
TP Total protein serum g/L 69.66±8.78 72.45±5.07 (−4.29, −1.29) <0.01
UA Uric acid serum μmol/L 246.25±78.04 241.26±58.18 (−9.46, 19.45) 0.5
RBC Red blood cell count full blood 1012/L 4.31±0.52 4.41±0.41 (−0.19, 0.005) 0.06
PCT Thrombocytocrit full blood L/L 0.27±0.1 0.23±0.07 (0.02,0.06) <0.01
CO2CP Carban dioxide-combining power serum mmol/L 24.54±2.97 24.03±2.36 (−0.05, 1.07) 0.08
TBIL Total bilirubin serum μmol/L 8.27±3.6 9.88±4.4 (−2.46, −0.77) <0.01
HCT Hematocrit full blood L/L 0.38±0.05 0.39±0.04 (−0.02, −0.002) 0.02
MONO% Monocyte ratio full blood % 5.77±2.01 5.4±1.82 (−0.03, 0.78) 0.07
MCV Mean corpuscular volume full blood fL 87.79±6.71 88.34±5.32 (−1.82, 0.72) 0.4
ALP Alkaline phosphatase serum u/L 86.56±57.77 67.98±19.61 (9.56, 27.59) <0.01